ARQT Competitors & Alternatives
Compare Arcutis Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
ARQT
Main Stock$25.94
Tradestie Score
57
Market Cap
$2.37B
Revenue Growth
0.6%
Analyst Upside
+33.5%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADMA
ADMA Biologics, Inc.
|
$8.74
|
$3.59B | 12.4 | 48 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$25.61
|
$3.58B | 11.7 | 58 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$292.04
|
$3.49B | 37.6 | 57 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.02
|
$3.40B | - | 46 | Compare |
|
QURE
uniQure N.V.
|
$44.06
|
$3.39B | - | 52 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$45.85
|
$3.33B | - | 52 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$27.49
|
$3.31B | - | 50 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.78
|
$3.09B | - | 52 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$32.61
|
$3.08B | - | 46 | Compare |
More ARQT Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry